Cellosaurus logo
expasy logo

Cellosaurus iOvCa241 (CVCL_VQ44)

[Text version]
Cell line name iOvCa241
Accession CVCL_VQ44
Resource Identification Initiative To cite this cell line use: iOvCa241 (RRID:CVCL_VQ44)
Comments Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
Sequence variations
Disease Low grade ovarian serous adenocarcinoma (NCIt: C105556)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 51Y
Category Cancer cell line
STR profile Source(s): PubMed=27822414

Markers:
AmelogeninX
CSF1PO12
D5S81812
D7S8208,10
D13S3179,11
D16S53912,14
D21S1132.2
TH016,9
TPOX8,11
vWA16,17

Run an STR similarity search on this cell line
Publications

DOI=10.14288/1.0319145
Dawson A.
Targeted therapy in low-grade serous ovarian carcinoma: characterization of MEK inhibitor response in novel patient-derived cell lines.
Thesis PhD (2016); University of British Columbia; Vancouver; Canada

PubMed=27822414; PMCID=PMC5088288
Fernandez M.L., DiMattia G.E., Dawson A., Bamford S., Anderson S., Hennessy B.T., Anglesio M.S., Shepherd T.G., Salamanca C.M., Hoenisch J., Tinker A., Huntsman D.G., Carey M.S.
Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.
Am. J. Cancer Res. 6:2235-2251(2016)

Cross-references
Cell line databases/resources cancercelllines; CVCL_VQ44
Encyclopedic resources Wikidata; Q94319943
Entry history
Entry creation07-Sep-2018
Last entry update19-Dec-2024
Version number7